JEROME MAXFIELD: Open Payments
NPI 1528129376 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 23 payments from 18 companies in 2025. Trend: 2023 $233 · 2024 $0 · 2025 $1,679
Food & beverage: $1,580Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $222 |
| AstraZeneca Pharmaceuticals LP | 3 | $215 |
| E.R. Squibb & Sons, L.L.C. | 2 | $192 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Kite Pharma, Inc. | 2 | $146 |
| Astellas Pharma Global Development | 1 | $126 |
| ABBVIE INC. | 1 | $123 |
| Daiichi Sankyo Inc. | 1 | $122 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $77 |
Products named: BRUKINSA, Padcev, Zynyz, ELAHERE, Enhertu, OPDIVO, NERLYNX, REBLOZYL.
Industry payments across DE — which companies pay providers there.
